BRCA1 L1780P reversion mutation confers resistance to PARP and ATM inhibitor in breast cancer

Sequencing data of breast cancer patients with BRCA1 L1780P including primary tissue and PDX models.携带乳腺癌易感基因1（BRCA1）L1780P突变的乳腺癌患者的测序数据，样本涵盖原发肿瘤组织与患者来源异种移植（PDX, Patient-Derived Xenograft）模型。